NEC member Eli Lilly and Company recently announced plans to open an innovation center in Cambridge, Massachusetts. The center will focus on drug delivery and device innovation, according to a press release from the company.
The company will immediately begin construction on the new center, to be located in Kendall Square, and expects employees to move in by the end of the year. Lilly plans to hire about 30 scientists and engineers over the next two years to get the center started. After the center is established, the company hopes to expand the staff and space to increase its delivery and device research.
“The Lilly Cambridge Innovation Center complements a deliberate push by the company to be an industry leader in providing convenient, reliable drug delivery and device innovation. Locating in Cambridge is an important strategic move for achieving this goa, as it provides us access to a concentration of high-caliber academic institutions, cutting-edge life sciences and technology companies, and some of the world’s leading talent,” said Dr. John Lechleiter, President, Chairman, and CEO of Eli Lilly and Company.
The New England Council applauds Eli Lilly for its dedication to innovation and is looking forward to watching the center grow within the vibrant health innovation culture of Cambridge.